| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |